Selective DNA delivery to tumor cells using an oligoarginine-LTVSPWY peptide

11Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

DNA therapy for cancer requires efficient, selective and safe DNA delivery systems. Compared with other non-viral methods such as lipid or polymer-based DNA delivery vectors, peptide-based DNA delivery systems are biocompatible and biodegradable, which leads to lower immunogenicity and lower toxicity. Moreover, peptide vectors are easier to produce and their compositions easier to control because solid-phase peptide synthesis has been extensively developed. However, peptide-based systems for DNA delivery toward special tumor cells or tissues are still lacking. In this study, we constructed a non-viral 9rR-LTVSPWY peptide-based DNA delivery system and showed that it is able to efficiently and selectively transfect DNA into targeted tumor cells. This work presents a novel strategy for tumor cell-specific DNA delivery and a reference for designing more efficient DNA delivery systems targeted towards various types of cancer.

Cite

CITATION STYLE

APA

Gong, C., Pan, D., Qiu, F., Sun, P., & Zhang, Y. H. (2014). Selective DNA delivery to tumor cells using an oligoarginine-LTVSPWY peptide. PLoS ONE, 9(10). https://doi.org/10.1371/journal.pone.0110632

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free